Lixte Biotechnology Holdings Inc Market Cap ($64.50 Million)
Market Cap & Net Worth: Lixte Biotechnology Holdings Inc (LIXT)
Lixte Biotechnology Holdings Inc market cap. Lixte Biotechnology Holdings Inc (NASDAQ:LIXT) has a market capitalization of $64.50 Million ($64.50 Million) as of November 4, 2026. Listed on the NASDAQ stock exchange, this USA-based company holds position #20708 globally and #4701 in its home market, demonstrating a -10.60% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Lixte Biotechnology Holdings Inc's stock price $3.71 by its total outstanding shares 17386450 (17.39 Million). Also see LIXT operating cash flow for how efficiently the company converts equity into cash flow.
Lixte Biotechnology Holdings Inc Market Cap History (2015–2026)
Lixte Biotechnology Holdings Inc market cap history from 2015 to 2026. Data shows change from $307.74 Million to $64.50 Million (-8.89% CAGR). Check current stock price of Lixte Biotechnology Holdings Inc for real-time trading data and today's change.
Index Memberships
Lixte Biotechnology Holdings Inc is a constituent of 2 market indices:
| Index | Total Market Cap | Weight (%) | Rank by Market Cap |
|---|---|---|---|
|
NASDAQ Health Care
IXHC
|
$2.61 Trillion | 0.00% | #584 of 976 |
|
NASDAQ Composite
IXIC
|
$40.20 Trillion | 0.00% | #1979 of 3165 |
Weight: Lixte Biotechnology Holdings Inc's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.
Lixte Biotechnology Holdings Inc Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Lixte Biotechnology Holdings Inc's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Explore Lixte Biotechnology Holdings Inc equity growth rate to track how rapidly the company is growing its equity base year over year.
Latest Price to Sales (P/S) Ratio
No P/S ratio data available
Latest Price to Earnings (P/E) Ratio
No P/E ratio data available
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| No financial ratio data available | |||||
Competitor Companies of LIXT by Market Capitalization
Companies near Lixte Biotechnology Holdings Inc in the global market cap rankings as of November 4, 2026. Also see Lixte Biotechnology Holdings Inc asset portfolio for a full breakdown of the balance sheet.
Key companies related to Lixte Biotechnology Holdings Inc by market ranking:
- Contemporary Amperex Technology Co Ltd Class A (SHE:300750): Ranked #144 globally with a market cap of $160.83 Billion USD ( CN¥1.10 Trillion CNY).
- ABB Ltd (SW:ABBN): Ranked #186 globally with a market cap of $127.26 Billion USD ( CHF100.66 Billion CHF).
- Vertiv Holdings Co (NYSE:VRT): Ranked #286 globally with a market cap of $90.85 Billion USD.
- Delta Electronics (Thailand) Public Company Limited (BK:DELTA): Ranked #378 globally with a market cap of $74.65 Billion USD ( ฿2.39 Trillion THB).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #144 | Contemporary Amperex Technology Co Ltd Class A | SHE:300750 | $160.83 Billion | CN¥249.32 |
| #186 | ABB Ltd | SW:ABBN | $127.26 Billion | CHF72.50 |
| #286 | Vertiv Holdings Co | NYSE:VRT | $90.85 Billion | $235.97 |
| #378 | Delta Electronics (Thailand) Public Company Limited | BK:DELTA | $74.65 Billion | ฿192.00 |
Market Capitalization of Lixte Biotechnology Holdings Inc (2015–2026)
Market capitalization of Lixte Biotechnology Holdings Inc from 2015 to today. Between 2015 and today, Lixte Biotechnology Holdings Inc's market cap moved from $307.74 Million to $ 64.50 Million, with a yearly change of -8.89%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | $64.50 Million | -5.60% |
| 2025 | $68.33 Million | +93.62% |
| 2024 | $35.29 Million | -13.63% |
| 2023 | $40.86 Million | -53.83% |
| 2022 | $88.50 Million | -57.23% |
| 2021 | $206.90 Million | -62.46% |
| 2020 | $551.17 Million | -22.19% |
| 2019 | $708.32 Million | -27.03% |
| 2018 | $970.69 Million | +463.94% |
| 2017 | $172.13 Million | +17.77% |
| 2016 | $146.15 Million | -52.51% |
| 2015 | $307.74 Million | -- |
End of Day Market Cap According to Different Sources
On Nov 4th, 2026 the market cap of Lixte Biotechnology Holdings Inc was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $64.50 Million USD |
| MoneyControl | $64.50 Million USD |
| MarketWatch | $64.50 Million USD |
| marketcap.company | $64.50 Million USD |
| Reuters | $64.50 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Lixte Biotechnology Holdings Inc
Lixte Biotechnology Holdings, Inc. develops utility-scale mobile energy storage systems on providing transportable solutions. It offers plug-and-play battery storage systems integrated into specially designed and patent-pending mobile energy storage systems and docking systems. The company's products include Traveler, a mobile battery energy storage system offering utility-scale power with 1 MW o… Read more